Global Action for Cancer Patients (GACP) was created in the spring of 2014. In the absence of a global cancer patient organisation, a small group of senior representatives from cancer patient organisations met in Toronto, Canada, to consider the key challenges facing cancer care in future years.
The unanimous view of the group confirmed a need to define ‘value’ in cancer care from a patient perspective. Decisions about access to care should reflect what matters to patients. In 2014, the issue of value in cancer care was not given a great deal of focus but since then it has become topical for patient groups, the biopharmaceutical industry and policy makers.
GACP wish to ensure that patient involvement in decision making becomes standard practice; make cancer survivorship and quality of life (QoL) higher priorities on the policy agenda; ensure that equity and access issues are always at the centre of policy conversations; and apply current trends in technology to benefit cancer patient management.